Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹919Cr
Rev Gr TTM
Revenue Growth TTM
4.01%
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

MANALIPETC
VS
| Quarter | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|
|
Growth YoY Revenue Growth YoY% | -19.4 | -7.1 | -5.5 | -13.9 | -23.2 | -20.2 | -14.7 | -4.2 | -10.1 | -2.4 | 7.7 | 25.9 |
| 327 | 294 | 255 | 200 | 239 | 220 | 226 | 183 | 209 | 212 | 228 | 233 |
Operating Profit Operating ProfitCr |
| 1.8 | 2.5 | 5.4 | 2.5 | 6.8 | 8.6 | 1.7 | 6.5 | 9.1 | 9.7 | 8.2 | 5.7 |
Other Income Other IncomeCr | 5 | 7 | 9 | 8 | 1 | 6 | 6 | 4 | 5 | 8 | 12 | 71 |
Interest Expense Interest ExpenseCr | 2 | 2 | 2 | 2 | 3 | 3 | 2 | 3 | 3 | 3 | 3 | 3 |
Depreciation DepreciationCr | 7 | 6 | 6 | 6 | 7 | 7 | 7 | 7 | 7 | 8 | 8 | 9 |
| 2 | 6 | 15 | 5 | 8 | 18 | 1 | 8 | 16 | 20 | 21 | 72 |
| 3 | 2 | 4 | 2 | 7 | 5 | 0 | 2 | 5 | 6 | 3 | 4 |
|
Growth YoY PAT Growth YoY% | -100.6 | -88.7 | -7.0 | -6.7 | 388.9 | 216.8 | -98.2 | 79.3 | 731.5 | 10.1 | 8,975.0 | 1,198.5 |
| -0.1 | 1.4 | 4.0 | 1.4 | 0.5 | 5.4 | 0.1 | 2.7 | 4.7 | 6.1 | 7.3 | 27.7 |
| 0.0 | 0.2 | 0.6 | 0.2 | 0.1 | 0.8 | 0.0 | 0.3 | 0.6 | 0.8 | 1.1 | 4.0 |
| Financial Year | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|
|
| | 9.2 | 18.3 | 8.3 | -0.9 | 27.6 | 63.2 | -29.6 | -12.3 | -13.1 | 7.0 |
| 512 | 572 | 651 | 712 | 733 | 724 | 1,143 | 1,103 | 988 | 839 | 882 |
Operating Profit Operating ProfitCr |
| 11.5 | 9.5 | 13.0 | 12.2 | 8.7 | 29.4 | 31.6 | 6.3 | 4.3 | 6.5 | 8.1 |
Other Income Other IncomeCr | 11 | 13 | 3 | 28 | 5 | -7 | 11 | 28 | 24 | 21 | 95 |
Interest Expense Interest ExpenseCr | 3 | 2 | 3 | 2 | 6 | 5 | 9 | 9 | 10 | 10 | 13 |
Depreciation DepreciationCr | 6 | 10 | 9 | 11 | 14 | 21 | 20 | 23 | 25 | 27 | 31 |
| 69 | 61 | 88 | 114 | 54 | 268 | 511 | 70 | 33 | 42 | 129 |
| 21 | 22 | 30 | 37 | 8 | 67 | 129 | 19 | 14 | 13 | 18 |
|
| | -17.5 | 46.4 | 32.3 | -39.1 | 331.3 | 89.4 | -86.7 | -62.1 | 52.6 | 281.2 |
| 8.3 | 6.3 | 7.7 | 9.4 | 5.8 | 19.6 | 22.8 | 4.3 | 1.9 | 3.3 | 11.6 |
| 2.8 | 2.3 | 4.2 | 4.5 | 2.7 | 11.7 | 22.2 | 3.0 | 1.1 | 1.7 | 6.5 |
| Financial Year | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|
Equity Capital Equity CapitalCr | 86 | 86 | 86 | 86 | 86 | 86 | 86 | 86 | 86 | 86 | 86 |
| 196 | 244 | 306 | 369 | 395 | 594 | 944 | 958 | 976 | 1,008 | 1,056 |
Current Liabilities Current LiabilitiesCr | 212 | 210 | 139 | 169 | 126 | 169 | 185 | 147 | 163 | 209 | 217 |
Non Current Liabilities Non Current LiabilitiesCr | 5 | 16 | 25 | 30 | 53 | 43 | 75 | 83 | 84 | 99 | 113 |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 355 | 273 | 250 | 342 | 310 | 550 | 908 | 674 | 701 | 692 | 735 |
Non Current Assets Non Current AssetsCr | 144 | 283 | 306 | 312 | 350 | 342 | 382 | 600 | 607 | 711 | 736 |
Total Assets Total AssetsCr |
| Financial Year | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Operating Cash Flow Operating Cash FlowCr | -6 | 87 | 58 | 13 | 87 | 219 | 373 | 92 | 75 | -19 |
Investing Cash Flow Investing Cash FlowCr | -7 | -124 | -22 | -17 | -21 | -15 | -13 | -267 | -82 | -155 |
Financing Cash Flow Financing Cash FlowCr | -11 | 6 | -17 | -2 | -29 | -28 | -26 | -64 | -7 | 0 |
|
Free Cash Flow Free Cash FlowCr | -6 | 87 | 58 | 13 | 87 | 219 | 373 | 92 | 75 | -19 |
| -12.4 | 220.8 | 100.4 | 17.6 | 187.3 | 108.6 | 97.9 | 181.3 | 388.6 | -64.8 |
CFO To EBITDA CFO To EBITDA% | -8.9 | 145.6 | 59.9 | 13.7 | 124.9 | 72.7 | 70.5 | 123.7 | 167.2 | -32.6 |
| Financial Year | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 432 | 687 | 576 | 436 | 174 | 1,020 | 1,864 | 1,034 | 967 | 966 |
Price To Earnings Price To Earnings | 9.3 | 18.2 | 10.0 | 5.7 | 3.7 | 5.1 | 4.9 | 20.4 | 50.2 | 33.0 |
Price To Sales Price To Sales | 0.8 | 1.1 | 0.8 | 0.5 | 0.2 | 1.0 | 1.1 | 0.9 | 0.9 | 1.1 |
Price To Book Price To Book | 1.5 | 2.2 | 1.5 | 1.0 | 0.4 | 1.5 | 1.8 | 1.0 | 0.9 | 0.9 |
| 6.3 | 11.4 | 6.0 | 4.1 | 2.0 | 2.5 | 2.4 | 8.8 | 12.7 | 13.1 |
Profitability Ratios Profitability Ratios |
| 31.6 | 29.3 | 33.6 | 34.5 | 30.0 | 46.2 | 45.4 | 28.7 | 30.8 | 35.4 |
| 11.5 | 9.5 | 13.0 | 12.2 | 8.7 | 29.4 | 31.6 | 6.3 | 4.3 | 6.5 |
| 8.3 | 6.3 | 7.7 | 9.4 | 5.8 | 19.6 | 22.8 | 4.3 | 1.9 | 3.3 |
| 25.1 | 17.8 | 21.9 | 23.7 | 11.9 | 39.3 | 49.6 | 7.5 | 4.0 | 4.3 |
| 17.0 | 12.0 | 14.8 | 16.8 | 9.7 | 29.6 | 37.0 | 4.8 | 1.8 | 2.7 |
| 9.6 | 7.1 | 10.4 | 11.7 | 7.1 | 22.6 | 29.5 | 4.0 | 1.5 | 2.1 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
### **Overview**
Manali Petrochemicals Limited (MPL), headquartered in Chennai, India, is a leading integrated petrochemical manufacturer and a part of the USD 2+ billion Singapore-based AM International group. MPL specializes in propylene glycol (PG), polyols, and a range of specialty chemicals. It is **India’s only fully integrated polyol producer**, with backward integration from propylene to polyol and derivative products. The company aims to transition toward a more sustainable and innovation-driven model, leveraging global acquisitions, R&D, and ESG-aligned strategies.
---
### **Strategic Direction (Current Focus: Nov 2025)**
As of Q3 2025, Manali Petrochemicals is undergoing a strategic shift from a commodity-focused business to a **balanced commodity-specialty portfolio** with a target revenue mix of **80% commodities and 20% specialty chemicals**. Growth is being driven by:
- Acquisition-led expansion
- Localization of production in India and Asia
- Sustainability and green innovation
- Market diversification across Asia-Pacific, Europe, and the Middle East
---
### **Key Developments (Latest Updates: Apr–Jun 2025)**
#### **1. Appointment of Mr. Sundar Saimani (Jun 2025)**
- Dr. Sundar Saimani, a PhD in Chemistry with post-doctoral research and over a decade of senior management experience from Dow Chemicals, has joined the leadership team.
- Brings deep expertise in **polyurethane systems, business development, and market expansion** in automotive, construction, and industrial sectors.
- Expected to strengthen MPL’s R&D and market positioning in high-growth polyurethane applications.
#### **2. Expansion into Asia-Pacific via Local Manufacturing (Apr 2025)**
- New manufacturing plant in Oragadam, Tamil Nadu (India), will serve as a **strategic base** for expansion into the Asia-Pacific region.
- Plant to be developed under **PennWhite India Private Limited**, a wholly owned subsidiary of PennWhite Limited (UK), which operates under MPL.
- Aims to localize production of **high-specification foam control agents** (defoamers), reducing import dependency and improving lead times.
#### **3. PennWhite India Manufacturing Facility (Apr 2025)**
- PennWhite India’s new facility will mirror the **quality standards** of its UK counterpart and pursue **equivalent international certifications**.
- Indian customers will be able to source **FoamDoctor®-grade defoamers domestically**, with **no change in performance or application**.
- Expected to increase **technical support availability, product customization**, and service efficiency for Indian clients.
#### **4. Acquisition & Integration Strategy**
- **2022 Acquisition**: MPL, through its subsidiary AMCHEM Singapore, acquired **Penn Globe Limited (PGL)** for GBP 24.98 million, bringing **Penn-White Limited** (antifoam leader) and **PennWhite Print Solutions Limited** under its umbrella.
- **2024 Incorporation**: **PennWhite India Private Limited** established in Chennai to serve Indian and South Asian markets.
- **Feb 2025**: PennWhite India acquired a **domestic Indian defoamer business**, including intellectual property (IP), portfolios, and customer contracts — the first step in a long-term India investment plan targeting the **fertilizer and food industries**.
---
### **Business Segments & Product Portfolio**
#### **Core Commodity Products (80% of revenue target)**
| Product | Capacity / Position | Key Applications |
|--------|----------------------|------------------|
| **Propylene Glycol (PG)** | ~100,000 tons/year (Sole Indian producer) | Pharmaceuticals, food & beverage, cosmetics, antifreeze |
| **Propylene Oxide (PO)** | India’s first & largest producer | Feedstock for PG, polyols, glycol ethers |
| **Polyols** | Integrated PO-PG-Polyols chain (100,000 T/month) | PU foams for insulation, furniture, automotive |
#### **Specialty & Niche Segments (20% target, high-margin)**
| Subsidiary | Product | Key Industries |
|----------|--------|----------------|
| **PennWhite (UK & India)** | FoamDoctor® antifoams, silicone emulsions, release agents, lubricants | Food processing, wastewater, oil & gas, coatings, printing |
| **Notedome (UK & Germany)** | Neuthane® polyurethane cast elastomers | Mining, defense, agriculture, subsea, energy |
| **In-house (MPL)** | Bio-based PU, green polyols, fire-resistant PIR | Sustainable manufacturing, construction, insulation |
---
### **Growth & Expansion Initiatives**
#### **1. India-Focused Manufacturing**
- **Project**: Greenfield defoamer plant in Oragadam, Tamil Nadu (via PennWhite India).
- **Investment**: Internally funded; part of a broader localization strategy.
- **Objective**: Capture 10% of India’s **35,000-ton foam control chemistry market**, particularly the premium 17,500-ton segment currently 50% import-dependent.
- **Synergy**: Access to local PO, polyols, and renewable energy from parent co.
#### **2. Polyol & Propylene Glycol Expansions**
| Project | Detail |
|-------|--------|
| **New PG Plant** | 32,000 MTPA capacity, ₹94 crores investment, 20.7% IRR |
| **Polyester Polyol Plant (Phase II)** | Under evaluation, to serve construction and elastomers |
| **Greenfield Polyol Expansion (West India)** | 30,000 MTPA, ₹130+ crores, 30% IRR, 5-year payback |
#### **3. Sustainability & Green Innovation**
- **Econic Technology MoU**: Deployment of CO₂-based catalysts to produce **sustainable polyols**.
- **Solar Energy Integration**: Planned solar panels to reduce OpEx and carbon footprint.
- **Bio-based R&D**: Supplying 100% bio-based crosslinkers to a UK customer; trialing 75% bio-based MDI prepolymer.
- **Low-carbon Formulations**: Water-based, vegetable oil-based defoamers with biodegradability and low toxicity.
---
### **Market Position & Competitive Landscape**
| Segment | Position |
|--------|---------|
| **India – PG & PO** | Sole domestic producer, market leader |
| **India – Polyols** | Only fully integrated PU manufacturer |
| **Global – Defoamers (PennWhite)** | Operates in 50+ countries, branded under **FoamDoctor®** |
| **Global – Cast Elastomers (Notedome)** | 45+ years, serves 40+ industries, $1.4B market, 5.3% CAGR |
| **India – Antifoam Market** | Targeting premium segment; limited local competition; global players (Dow, Henkel) avoid overlap |
**Competitive Advantages:**
- Vertical integration (from propylene to final products)
- Lower forex risk due to local manufacturing
- Strong R&D and formulation expertise
- Focus on **value-added, high-performance solutions** over price
- Sustainability-driven customer partnerships
---
### **Financial & Operational Highlights**
- **Revenue Mix (Target)**: 80% commodities, 20% specialty chemicals
- **Historical Revenue (FY22)**: ₹1,690 crores | **EBITDA**: ₹547 crores
- **Capex Strategy**: Brownfield and greenfield expansions funded via accruals and debt (e.g., 50:50 debt-equity for new PG plant)
- **Margin Drivers**: Operational efficiency, portfolio restructuring, cost leadership in energy and raw materials
- **Propylene Dependency**: Major input sourced from crude oil; benefits from declining Brent prices
- **Rupee Risk Mitigation**: Local production for Asian markets reduces USD/INR exposure
---
### **Leadership & Governance**
- **MD**: Mr. Muthukrishnan Ravi – Key driver of international acquisitions and export strategy.
- **CEO – PennWhite Ltd**: Mr. Tobias Tasche (appointed Jul 2023) – Former Shell executive, 25 years in specialty chemicals and supply chain.
- **New Leadership (Jun 2025)**: Dr. Sundar Saimani – Strengthening technical leadership in polyurethanes and PU systems.
---
### **Geographic & Market Strategy**
| Region | Strategy |
|--------|---------|
| **India** | Localization of defoamer and specialty chem production; expand PG and PU captive consumption |
| **Asia-Pacific** | Manufacturing hub in Tamil Nadu to serve SEA, Japan, Australia |
| **Europe & UK** | Direct sales growth, strategic distribution (e.g., with KRAHN UK for silicone oils), rebranding and integration |
| **Middle East & Africa (MENA)** | Strengthen distribution via trade shows and partnerships |
| **Nordics & Spain** | New distribution agreements underway; expansion in energy and cable sectors |
---
### **Challenges**
- **Propylene Supply Constraints**: High domestic prices and limited availability affecting polyol utilization.
- **Import Competition**: Uncontrolled imports in PU sector; anti-dumping duties only partially effective.
- **Supplier Concentration**: 46% raw material purchases from Dow (as of Dec 2022).
- **Margin Pressure**: From rising input costs, although partially offset by adaptive pricing and efficiency measures.